MedPath
NMPA Approval

Levonorgestrel Intrauterine System(Ⅲ)

H20180096

Bayer Oy

December 25, 2018

Drug Information

左炔诺孕酮宫内节育系统(Ⅲ)

宫内节育系统

13.5mg

化学药品

December 25, 2018

December 24, 2023

Company Information

Applicant Company

Bayer Oy

Pansiontie 47,20210 Turku,Finland

Manufacturing Company

Bayer Oy

Pansiontie 47,20210 Turku,Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左炔诺孕酮宫内节育系统(Ⅲ) - NMPA 批准文号 | MedPath